CannaPharmaRX, Inc. (OTCPK: CPMD)
Health Care · Pharmaceuticals · CA
$0.00
-5.00% today · -36.7% 1Y
CannaPharmaRX, Inc. (OTCPK: CPMD) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.28M and employs 26 people.
Over the last twelve months the share price has lost 36.7%, trading between 0.00 and 0.01.
Tweenvest scores CannaPharmaRX, Inc. across four factors: quality 18/100, value 72/100. Its strongest factor is value.
CPMD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.28M
- Revenue (TTM)
- $1.70M
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- -1,518.55
- 52-week high
- $0.01
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 672.27M
- Employees
- 26
- Next earnings
- —
About CannaPharmaRX, Inc.
CannaPharmaRX, Inc. is a Canadian enterprise actively involved in the cannabis sector. The company focuses on identifying, acquiring, and developing diverse projects for cultivating cannabis. Founded in 1998, its main offices are located in Calgary, Canada.
- ISIN
- US13765D1090
- Listed since
- Oct 29, 1999
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,199.25 | -2.79% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.42 | -1.00% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $154.02 | -1.55% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.40 | -0.60% |
Figures last refreshed Aug 18, 2026.